Vascular occlusion in the chin: signs and initial management

· 7 min read

Editorial illustration of vascular occlusion in the chin
  • Artery
  • Highlighted area
Illustrative diagram, simplified and not to scale: submental artery (profile view).

Quick facts

Arteries involved
Submental, mental and inferior labial, branches of the facial artery
Where it appears
Skin of the chin, labiomental fold and lower lip
Common trap
Mistaking swelling and the pallor of a mental nerve block for ischemia
Extra risk
Hematoma in the floor of the mouth and under the chin

The chin is one of the most rewarding and, at the same time, most underestimated areas in HOF. A well-planned volume improves chin projection and the balance of the profile, and the procedure is considered lower in vascular risk than the forehead, glabella or nose. Even so, the skin of the chin and lower lip is supplied by branches of the facial artery, and a vascular occlusion there, although rare, can cause necrosis in a very visible area. This text brings together signs and initial management, at review level.

The page does not teach technique or include doses or dilutions. The general concept is in vascular occlusion. For the procedure itself, see chin filler and aging of the chin and jaw.

Which arteries supply the chin?

The area depends on a network of branches that communicate with each other.

  • Submental artery: branch of the facial artery that runs under the body of the mandible and gives branches to the chin area and muscle.
  • Mental artery: emerges through the mental foramen together with the mental nerve and supplies the skin of the chin and the lower lip.
  • Inferior labial artery: runs along the lower lip and communicates with the branches of the chin.
  • Branches of the sublingual artery and anastomoses with the contralateral territory.

These arteries form wide anastomoses, so a localized compromise can show up beyond the point you imagine. The proximity to the mental foramen and the mentalis muscle makes the area a territory with nerves and vessels to keep in mind. See the review vascular anastomoses of the face.

Signs of occlusion in the chin

The presentation follows the general pattern, with a distribution that reflects the arteries involved.

Phase Most cited signs Observation in the chin
During injection Sudden pallor, disproportionate pain May appear on the chin, labiomental fold or lower lip
Minutes Net-like violet color (livedo), slow capillary refill Compare with the opposite side
Hours Increasing pain, localized swelling, darkening Pain may be masked by the anesthetic
Days Blisters, scabs, ulceration Attention to the chin skin, where healing is visible
Weeks Scarring, change in contour Prolonged follow-up

How do you tell it from benign conditions?

The chin swells, flushes and turns pale for various reasons, and assessment calls for calm.

Condition How it presents Difference from occlusion
Anesthetic pallor Skin lightens for a while after a block with a vasoconstrictor Improves with time, with no increasing pain or violet net. See occlusion or anesthesia pallor
Swelling Diffuse puffiness, normal color Capillary refill preserved
Bruise Purple patch, evolves through colors Does not blanch, does not follow an arterial course
Pressure from the product itself Transient blanching under compression Returns to normal when relieved
Vascular occlusion Pallor, violet net, increasing pain Territory of one artery, progression over hours

When doubt persists, the guideline advice is to treat it as a suspected vascular event.

The chin hematoma also deserves attention

There is one specific point: the submental area is contiguous with the floor of the mouth, and significant bleeding there can compress deep structures. Although rare with injectables, swelling that grows rapidly, with difficulty swallowing, speaking, breathing or moving the tongue, is an emergency that should not be treated as an ordinary bruise. In those cases, referral is immediate. The general approach to bleeding is in expanding hematoma in the face.

Prevention is partly possible: reviewing anticoagulants and other medications in the medical history, noting varicose or visible vessels and choosing the instrument carefully.

Initial management when occlusion is suspected

At review level, the first response is usually:

  1. Stop the injection and do not add product.
  2. Examine the chin, the labiomental fold and the lower lip, and compare with the opposite side.
  3. With hyaluronic acid, use hyaluronidase according to guidelines and the professional's judgment, reassessing perfusion.
  4. Adjuvant measures and medications vary between protocols, and prescribing is a medical decision.
  5. Record start time, findings, photos and actions.
  6. Keep under observation and arrange a short follow-up and contact.
  7. Refer in case of worsening, an extensive area, general symptoms or any sign outside what is expected.

Details on stock and team preparation are in hyaluronidase in the clinic.

Why does chin planning deserve extra care?

Part of the safety lies in deciding well what and how much to treat. The chin takes part in the balance of the profile, and many concerns that seem to be about the chin are actually about the relationship between lips, nose and jaw. The assessment of the retrognathic profile helps in understanding when filler is a reasonable answer and when another path (orthodontics, surgery) should be discussed. Likewise, a double chin concern may call for a different approach, as in double chin: assessment.

Three practical principles reduce risk and frustration:

  • Conservative volume per session, with reassessment at follow-up.
  • Aligned expectations: the chin gains projection, it does not get "swapped".
  • Respect for natural asymmetry, explained and recorded before injecting.

Patient instructions

Mild swelling, firmness and tenderness in the first few days are expected. What is not expected: pain that increases, white, purplish net-like or dark skin, blisters, or swelling that grows rapidly. Give the instructions in writing and confirm the phone number.

Touch-ups, maintenance and new sessions

After a complication, returning to the chin takes time and caution. Resume treatment only when the area is stable and the conversation about what happened is clear. The decision to repeat the filler, change the approach or give up on the area is shared with the patient and recorded. For day-to-day use, post-procedure instructions and the post-procedure checklist help standardize follow-up.

In Harmy

Summary

The chin carries lower vascular risk than other areas, but not zero. Watch for pallor, disproportionate pain and a violet net on the chin and lower lip, remember that the mental nerve block disguises pain and that growing submental swelling can be an emergency. Keep the enzyme, the protocol and an honest conversation with the patient as part of the routine.

Frequently asked questions

Does chin filler carry a risk of necrosis?

The risk is low compared with other areas, but it exists. Branches of the facial artery, such as the submental and inferior labial arteries, supply the area, and an occlusion can cause ischemia of the chin skin and lower lip.

How do you identify an occlusion in the chin?

The signs are usually sudden pallor or blanching, disproportionate pain, a violet net-like color and slow capillary refill, which can extend to the lower lip or the labiomental fold following the arterial course.

Is pallor after a mental nerve block an occlusion?

Not necessarily. The anesthetic and the vasoconstrictor can lighten the skin for a while. What tells them apart is the course: pallor that persists, increasing pain and livedo suggest ischemia, and numbed skin can hide the pain.

Is a hematoma in the chin an emergency?

Small, stable bruises are usually monitored. Swelling that grows, with difficulty swallowing, breathing or moving the tongue, is an emergency, because bleeding in the submental area can compress structures of the floor of the mouth.

Harmy images are illustrative simulations generated by AI from the patient's photo to support the conversation between practitioner and patient. They are not a promise of results. Indication, technique, product and volume are solely the decision of the licensed practitioner. This content is for information only and does not replace a clinical assessment.

Terms mentioned

Related reading